These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7233375)
41. [Lidocaine in the acute phase of myocardial infarct]. Samson M Laval Med; 1971 Mar; 42(3):304-5. PubMed ID: 5573032 [No Abstract] [Full Text] [Related]
42. [Lidocaine as an anti-arrhythmia agent. Experiences with 68 patients]. Flensted-Jensen E; Sandoe E Ugeskr Laeger; 1969 Mar; 131(12):504-7. PubMed ID: 5793605 [No Abstract] [Full Text] [Related]
43. [Lidocaine concentrations to arterial blood after transtracheal injection and laryngo-tracheal spraying (author's transl)]. Asada A; Nishimura K; Fujimori M Masui; 1978 Jul; 27(7):719-26. PubMed ID: 691234 [No Abstract] [Full Text] [Related]
44. Logical approach to lignocaine therapy. Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716 [TBL] [Abstract][Full Text] [Related]
45. [The effect of intravenous lidocaine on myocardial contractility during halothane anesthesia in man--a study by non-invasive measurement of left ventricular systolic time intervals (author's transl)]. Yamaoka H Masui; 1981 Jan; 30(1):14-9. PubMed ID: 7218506 [No Abstract] [Full Text] [Related]
50. [Pharmaco-kinetics and modes of prescription of lidocaine]. Derrida JP; Chiche P Coeur Med Interne; 1977; 16(1):103-8. PubMed ID: 852244 [No Abstract] [Full Text] [Related]
51. [Effectiveness of lidocaine use in the initial period of acute myocardial infarct]. Iosava KV; Areshidze TKh; Lezhava MG; Gaprindashvili TG Kardiologiia; 1982 Dec; 22(12):82-5. PubMed ID: 6186836 [TBL] [Abstract][Full Text] [Related]
52. Lidocaine therapy with an exponentially declining infusion. Clinical evaluation of an optimized dosing technique. Sebaldt RJ; Nattel S; Kreeft JH; Ogilvie RI Ann Intern Med; 1984 Nov; 101(5):632-4. PubMed ID: 6486594 [TBL] [Abstract][Full Text] [Related]
53. [Kinetics and tolerance of a combined intravenous and oral dose of mexiletine during the sub acute phase of myocardial infarction (author's transl)]. Leizorovicz A; Pignat E; Mille A; Boissel JP; Ferry S; Guilluy M; Touboul P Therapie; 1981; 36(4):413-20. PubMed ID: 7027523 [No Abstract] [Full Text] [Related]
55. [The effect of furosemide in acute myocardial infarction (author's transl)]. Málek I; Gebauerová M; Jedlicka J; Richterová J; Stanĕk V Cas Lek Cesk; 1982 Apr; 121(15):462-6. PubMed ID: 7083291 [No Abstract] [Full Text] [Related]
56. Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death. Shand DG; Pritchett EL; Hammill SC; Stargel WW; Wagner GS Ann N Y Acad Sci; 1982; 382():238-46. PubMed ID: 7044243 [No Abstract] [Full Text] [Related]
57. Age-dependent lidocaine disposition in patients with acute myocardial infarction. Cusson J; Nattel S; Matthews C; Talajic M; Lawand S Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999 [TBL] [Abstract][Full Text] [Related]
58. Immediate treatment of myocardial infarction. D'Cunha GF; Hughes G; Friedberg HD Wis Med J; 1971 Apr; 70(4):111-2. PubMed ID: 5550511 [No Abstract] [Full Text] [Related]
59. [Lignocaine in the treatment of arrhythmia]. Gürtler-Krawczyńska E Wiad Lek; 1971 Jun; 24(12):1205-9. PubMed ID: 5561278 [No Abstract] [Full Text] [Related]